Bone growth stimulator
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Bone</strong> <strong>growth</strong> <strong>stimulator</strong> Market<br />
<strong>Bone</strong> <strong>growth</strong> <strong>stimulator</strong>s are used to compensate for the delay or failure of fracture healing<br />
since they fasten the bone-healing process without passing any electrical shocks when<br />
worn. An internal bone <strong>growth</strong> <strong>stimulator</strong> is kept on the fusion site of the bone for about 6<br />
to 12 months and it releases small electrical currents. External bone <strong>growth</strong> <strong>stimulator</strong> is<br />
worn externally and does not need any surgical implantation.<br />
Global <strong>Bone</strong> Growth Stimulators Market was worth USD 1.13 billion in 2018 and estimated<br />
to be growing at a CAGR of 5.3%, to reach USD 1.42 billion by 2023. The market is predicted<br />
to grow at a significant potential during the specified period. It will keep growing with the<br />
recent developments in medical sector.<br />
Financial feasibility for example development in the service sector, <strong>growth</strong> of disposable<br />
income and spending on healthcare sector are estimated to drive the market <strong>growth</strong><br />
globally. But, many factors like the availability of other options, doubtfulness of efficacy,<br />
equipment-related problems and competition from bone grafting act as restraints for the<br />
<strong>growth</strong> of bone <strong>growth</strong> <strong>stimulator</strong>s market.<br />
The Global <strong>Bone</strong> Growth Stimulators market is broadly categorized on the basis of Product<br />
into <strong>Bone</strong> Growth Stimulation Devices, <strong>Bone</strong> Morphogenetic Proteins and Platelet-rich<br />
Plasma. The bone <strong>growth</strong> stimulation devices is further segmented into External <strong>Bone</strong><br />
Growth Stimulators, Implanted <strong>Bone</strong> Growth Stimulators and Ultrasonic <strong>Bone</strong> Growth<br />
Stimulators. Based on Application, the market is segmented into Spinal Fusion Surgeries,<br />
Delayed Union & Nonunion <strong>Bone</strong> Fractures, Oral and Maxillofacial Surgeries and Other<br />
Applications. On the basis of End User, the market is classified into Hospitals and Clinics,<br />
Home Care, Academic & Research Institutes and CROs.<br />
On the basis of region the global market is segmented into North America, Asia-Pacific,<br />
Europe, Latin America and Middle-East and Africa. As of 2016, the global bone <strong>growth</strong><br />
<strong>stimulator</strong>s market was led by North America owing to the growing geriatric population,<br />
rising instances of arthritis and sports injuries and increasing demand for less invasive spinal<br />
surgeries. However, the Asia-Pacific market is estimated to grow at the highest CAGR during<br />
the forecast period because of a huge patient pool for the diseases, growing awareness<br />
about treatment options and government support<br />
The major players dominating the <strong>Bone</strong> Growth Stimulators market are DJO LLC, Orthofix<br />
International N.V., Zimmer Biomet Holdings Inc., Elizur, Bioventus LLC., Ossatec Benelux BV,<br />
Verve Consulting Inc., and IGEA S.p.A.<br />
TABLE OF CONTENTS<br />
1. Introduction<br />
1.1 Market Definition<br />
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
Change language